drugset / Trial / NCT06362590
Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
Summary
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | ladiratuzumab vedotin | Unknown | — | — |
Indications
No indication recorded.